Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Noninvasive Arterial Input Estimation for O-15 PET
NCT03806751Phase 1Withdrawn
- Sponsor
- University of Alabama at Birmingham
- Start
- Feb 2025
- Primary completion
- Feb 2027
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial, sponsored by University of Alabama at Birmingham. Primary endpoint: Comparison of arterial sampling to non-invasive methods to measure regional cerebral blood flow at 3 years. Planned start Feb 2025; status: withdrawn.
Beyond the preview
Go deeper on NCT03806751.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03806751.